Peter Evan Harwin
Director; Director, 10% Owner · 10 filings · Latest: Jul 1, 2026
Apogee Therapeutics, Inc.
Cogent Biosciences, Inc.
CRESCENT BIOPHARMA, INC.
Damora Therapeutics, Inc.
Galecto, Inc.
Jade Biosciences, Inc.
Oruka Therapeutics, Inc.
Spyre Therapeutics, Inc.
Zenas BioPharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
ORKA | Peter Evan Harwin | Director, 10% Owner | Jul 1, 2026 | Sale | $84.43 | 3,553,410 | $300.0M | 1,131,954 | |
SYRE | Peter Evan Harwin | Director | Jun 23, 2026 | Sale | $85.31 | 4,684,781 | $399.7M | 0 | |
ZBIO | Peter Evan Harwin | Director | Mar 31, 2026 | Purchase | $20.00 | 150,000 | $3.0M | 2,359,025 | |
GLTO | Peter Evan Harwin | Director, 10% Owner | Feb 9, 2026 | Option Exercise | $0.00 | 8,713,000 | — | 2,904,000 | |
APGE | Peter Evan Harwin | Director | Jan 22, 2026 | Sale | $76.30 | 1,750,000 | $133.5M | 298,647 |